AD/PD™ focuses on basic science and translational and clinical research to bring you:
- New insights on disease mechanisms and etiologies.
- The latest findings from clinical trials.
- Innovative outlooks on therapy and prevention.
- Advances in diagnostic markers.
- Successful strategies to enhance collaboration.
- A great opportunity to interact with peers and experts.
The conference has grown to be the leading event in the field of neurodegenerative disorders with over 4,700 participants from 70+ countries and over 2,250 abstracts in 2024.